Washington Vertex Pharmaceuticals

FDA, opioid and Vertex

FDA OK's painkiller designed to end opioids' addiction and overdose risk

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' pill,

CNBC on MSN · 13h

FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.

MarketWatch · 3h

Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.

Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment.

16hon MSN

Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX)’s Suzetrigine: ‘I Don’t See A Lot Of Upside Because That Was The Drug Of The Future For Vertex’

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

Vertex Pharmaceuticals’ JOURNA VX: Navigating Market Challenges Despite Promising Financial Outlook

Needham analyst Joseph Stringer has maintained their neutral stance on VRTX stock, giving a Hold rating today.Invest with Confidence: Follow ...

The Tokenist2h

Vertex Pharmaceuticals Stock Soars as Non-Opiod Pain Treatment Gets FDA Nod

Vertex Pharmaceuticals' newly FDA-approved non-opioid analgesic, Journavx, offers a groundbreaking alternative for managing ...

NBC News on MSN13d

'Will it really work?': Young sickle cell patient among the first to start new gene therapy

Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...

Nasdaq5d

Is Vertex Pharmaceuticals Stock a Buy in 2025?

Vertex has built an empire in cystic fibrosis (CF) treatment, recently crowning its dominance with Alyftrek's approval last month. This latest CF drug adds even more firepower to a franchise ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results